The pharmacokinetics of clarithromycin and its 14-OH metabolite.
about
Resistance of M. leprae to quinolones: a question of relativity?Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.The new macrolides. Azithromycin and clarithromycin.Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.Use of anti-infective agents during lactation: Part 2--Aminoglycosides, macrolides, quinolones, sulfonamides, trimethoprim, tetracyclines, chloramphenicol, clindamycin, and metronidazole.Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.Microdosing and drug development: past, present and futureModeling the autoinhibition of clarithromycin metabolism during repeated oral administrationInterethnic differences in pharmacokinetics of antibacterials.Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidApplication of lactobionic acid and nonionic surfactants as solubilizing agents for parenteral formulation of clarithromycin.Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.Bilateral diffuse iris atrophy after the use of oral clarithromycin.RP-HPLC Method Development and Validation for Simultaneous Estimation of Clarithromycin and Paracetamol
P2860
Q28535115-3B52734C-E9E8-4C85-B172-BC691D32D94CQ33163019-B53CD832-0B22-410F-A043-EDF5759C76F7Q33598839-87CC2C0B-8375-435E-90DB-2BED9B990B2CQ33607251-898DBE46-BC0D-4023-91E5-4CA6CDA60CA0Q33703410-EAECA806-F55E-4A3C-A08E-27F2565D8180Q34533754-F64C0134-015F-4135-9D07-951773857A06Q35111440-D82AEDD2-B20D-4D5C-8CFD-ECDAAB87491EQ35940544-1059B471-C99C-4333-8C26-36E29C1A02CFQ37247655-C61CED0A-51BF-4295-91F6-C73194347800Q38266806-41F94E66-1D0A-4E88-B3F8-2FC111D9D78FQ38287050-451C2D61-84B1-48F7-A34D-4DA677329EB3Q39878304-E843FF3E-2770-4547-86E8-0E0411709860Q40600560-F05D688F-CACD-4B34-9BC8-1E1434D3A74AQ42012986-6F19B866-6F7A-4103-AA29-B4DBF8F2D06FQ44770176-4449735F-B20F-46D2-9FC9-419E8BC74A9BQ46741874-2CC4CDB1-6A60-48A9-9F42-D4CE25BDF6AAQ59001375-6F68DC08-AA06-4398-A3E1-F0E1F440B77D
P2860
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@ast
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@en
type
label
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@ast
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@en
prefLabel
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@ast
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@en
P1476
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
@en
P2093
P356
10.1016/0195-6701(91)90215-T
P478
19 Suppl A
P577
1991-09-01T00:00:00Z